Efinopegdutide dose guide

A peptide dosage chart, one peptide at a time: its dose range, how often it’s taken, a typical run and the units on your syringe. 84 peptides from the PepVault library.

A community reference, not medical advice. Each range is what has been studied or is commonly run, never a dose for you.

Efinopegdutide dosage

A once-weekly GLP-1 and glucagon dual agonist that Merck is developing for MASH, the inflamed form of fatty liver disease. In its 52-week phase 2b trial, about 6 in 10 people on it had their liver inflammation resolve on biopsy, against about 1 in 8 on placebo, and at 7 mg about half saw their liver scarring improve. In a 24-week trial it cut liver fat by about 73%, against 42% on semaglutide 1 mg. Commonly reported: GI side effects during step-ups, and weight loss too. Not approved anywhere.

Dose range
4–10 mg (research range). Trials and labels start at 2 mg and step up. Studied in research — not a recommendation.
How often
Weekly
A typical run
Ongoing. Used continuously, once weekly, in its trials: 24 to 52 weeks, stepping up every 4 weeks from 2 mg in the MASH trial. No trial has tested stopping it.
How it’s taken
Vial: SubQ injection
Evidence
Moderate: Animal studies + some human data
Half-life
Not reported in an open human PK source; dosed once weekly in all its trials

Efinopegdutide on your syringe

With a 10 mg vial and 2 mL of water (5 mg in every mL), on a 1 mL (100-unit) U-100 insulin syringe: the low end, 4 mg, is 80 units; and the high end, 10 mg, needs a stronger mix than one syringe holds. 2 doses in the vial at the low end. All U-100: 100 units to the mL. A U-40 syringe reads differently.

Newsletter · Weekly

The weekly peptide briefing.

New guides, the week’s peptide news, one tool. Free, one email a week, unsubscribe anytime.

We’ll email you a link to confirm. Your address is used for the briefing only. Privacy

Track the doses you run

PepVault logs every dose, keeps count of the doses left in your vials, and reminds you on your schedule.

Get PepVault on the App Store7 days free on the yearly plan for new subscribers.

More glp-1 & metabolic peptides

A community reference, not medical advice. Each range is what has been studied or is commonly run, never a dose for you.